Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Mehr anzeigen
Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain...
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.5597 | 0.5597 | 0.5597 | 0 | 0 | CS |
| 4 | -1.0803 | -65.8719512195 | 1.64 | 2.1058 | 0.5269 | 176536 | 1.01703116 | CS |
| 12 | -4.6503 | -89.2571976967 | 5.21 | 5.97 | 0.5269 | 174147 | 3.19272245 | CS |
| 26 | -6.3863 | -91.942124964 | 6.946 | 7.9 | 0.5269 | 190477 | 5.10664149 | CS |
| 52 | -11.6403 | -95.412295082 | 12.2 | 19.9 | 0.5269 | 288591 | 8.18999979 | CS |
| 156 | -214.4403 | -99.7396744186 | 215 | 287.5 | 0.5269 | 844749 | 96.83246552 | CS |
| 260 | -214.4403 | -99.7396744186 | 215 | 287.5 | 0.5269 | 844749 | 96.83246552 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
